Work

Abstract CT090: A phase 1b/2 study of ramucirumab in combination with emibetuzumab in patients with advanced solid tumors

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2017-ct090

Authors: Johanna Bendell, Charles Fuchs, Martin Voss, Todd M. Bauer, Toni K. Choueiri, Alexander Drilon, Katharine Thorn, Sameera Wijayawardana, Brian Moser, Arantxa Uruñuela, Volker Wacheck, James J. Harding

Institutions: Tennessee Oncology, Yale Cancer Center, Yale University, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Eli Lilly (United States)

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2741748273

Cites:

Cited by: 1

Related to: 10